Literature DB >> 16401576

Effect of cryoprotectants on the reconstitution of surfactant-free nanoparticles of poly(DL-lactide-co-glycolide).

Y-I Jeong1, Y-H Shim, C Kim, G-T Lim, K-C Choi, C Yoon.   

Abstract

Various cryoprotectants were tested to reconstitute the surfactant-free nanoparticles of poly(DL-lactide-co-glycolide) (PLGA). When 2.0% (w/v) of sucrose, trehalose and lactose were used, nanoparticles were completely reconstituted into aqueous solution and particle size was not significantly changed. Above 1.0% (w/v) of sucrose, trehalose and lactose, nanoparticles are well reconstituted whereas it was precipitated with 1.0% (w/v) of mannitol. Drug-encapsulated surfactant-free nanoparticles were quite reconstituted when 2.0% (w/v) of sucrose, trehalose and lactose. Drug release kinetics of nanoparticles was not significantly changed by cryoprotectants.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16401576     DOI: 10.1080/02652040500162659

Source DB:  PubMed          Journal:  J Microencapsul        ISSN: 0265-2048            Impact factor:   3.142


  9 in total

1.  Surfactant-free formulation of poly(lactic/glycolic) acid nanoparticles encapsulating functional polypeptide: a technical note.

Authors:  Yu-Chao Wang; Yi-Ting Wu; Hsin-Ying Huang; Chung-Shi Yang
Journal:  AAPS PharmSciTech       Date:  2009-10-29       Impact factor: 3.246

2.  Preserving enhancement in freeze-dried contrast agent ST68: Examination of excipients.

Authors:  Carl Solis; Flemming Forsberg; Margaret A Wheatley
Journal:  Int J Pharm       Date:  2010-06-09       Impact factor: 5.875

3.  Effect of sugars, surfactant, and tangential flow filtration on the freeze-drying of poly(lactic acid) nanoparticles.

Authors:  Samuli Hirsjärvi; Leena Peltonen; Jouni Hirvonen
Journal:  AAPS PharmSciTech       Date:  2009-04-21       Impact factor: 3.246

4.  Stabilization of aerosolizable nano-carriers by freeze-drying.

Authors:  Claudia B Packhaeuser; Kerstin Lahnstein; Johannes Sitterberg; Thomas Schmehl; Tobias Gessler; Udo Bakowsky; Werner Seeger; Thomas Kissel
Journal:  Pharm Res       Date:  2008-10-08       Impact factor: 4.200

5.  Physicochemical and Biological Evaluation of Curdlan-Poly(Lactic-Co-Glycolic Acid) Nanoparticles as a Host-Directed Therapy Against Mycobacterium Tuberculosis.

Authors:  S D'Souza; S M Du Plessis; S Egieyeh; R B Bekale; R E Maphasa; A F Irabin; S L Sampson; A Dube
Journal:  J Pharm Sci       Date:  2021-09-14       Impact factor: 3.534

6.  Effect of cryoprotectants on the porosity and stability of insulin-loaded PLGA nanoparticles after freeze-drying.

Authors:  Pedro Fonte; Sandra Soares; Ana Costa; José Carlos Andrade; Vítor Seabra; Salette Reis; Bruno Sarmento
Journal:  Biomatter       Date:  2012 Oct-Dec

7.  Investigation and optimization of formulation parameters on preparation of targeted anti-CD205 tailored PLGA nanoparticles.

Authors:  Sheikh Tasnim Jahan; Azita Haddadi
Journal:  Int J Nanomedicine       Date:  2015-12-10

Review 8.  Nanomilling of Drugs for Bioavailability Enhancement: A Holistic Formulation-Process Perspective.

Authors:  Meng Li; Mohammad Azad; Rajesh Davé; Ecevit Bilgili
Journal:  Pharmaceutics       Date:  2016-05-20       Impact factor: 6.321

9.  Long-term storage of lipid-like nanoparticles for mRNA delivery.

Authors:  Pengxuan Zhao; Xucheng Hou; Jingyue Yan; Shi Du; Yonger Xue; Wenqing Li; Guangya Xiang; Yizhou Dong
Journal:  Bioact Mater       Date:  2020-03-18
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.